UBS Group’s InMed Pharmaceuticals INM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.2K | Buy |
8,068
+7,691
| +2,040% | +$7.25K | ﹤0.01% | 8820 |
|
|
2025
Q4 | $400 | Buy |
+377
| New | +$626 | ﹤0.01% | 9984 |
|
|
2025
Q3 | – | Sell |
-7,762
| Closed | -$25.2K | – | 10590 |
|
|
2025
Q2 | $25.2K | Buy |
7,762
+1,656
| +27% | +$4.59K | ﹤0.01% | 8292 |
|
|
2025
Q1 | $12.6K | Sell |
6,106
-4,302
| -41% | -$14.4K | ﹤0.01% | 8486 |
|
|
2024
Q4 | $49.3K | Sell |
10,408
-194
| -2% | -$937 | ﹤0.01% | 7305 |
|
|
2024
Q3 | $50.3K | Buy |
+10,602
| New | +$54K | ﹤0.01% | 6820 |
|
|
2024
Q2 | – | Sell |
-2
| Closed | -$15 | – | 9778 |
|
|
2024
Q1 | $15 | Buy |
+2
| New | +$15 | ﹤0.01% | 9062 |
|
|
2023
Q4 | – | Sell |
-3
| Closed | -$48 | – | 9586 |
|
|
2023
Q3 | $48 | Buy |
+3
| New | +$55 | ﹤0.01% | 9009 |
|
|
2023
Q2 | – | Sell |
-131
| Closed | -$2.83K | – | 9243 |
|
|
2023
Q1 | $2.83K | Buy |
131
+89
| +212% | +$2.88K | ﹤0.01% | 8433 |
|
|
2022
Q4 | $1.68K | Sell |
42
-248
| -86% | -$16.7K | ﹤0.01% | 9815 |
|
|
2022
Q3 | $38K | Buy |
+290
| New | +$53.6K | ﹤0.01% | 6612 |
|
|
2021
Q4 | – | Sell |
-10
| Closed | -$9K | – | 10466 |
|
|
2021
Q3 | $9K | Buy |
10
+6
| +150% | +$7.15K | ﹤0.01% | 8093 |
|
|
2021
Q2 | $7K | Buy |
4
+2
| +100% | +$3.1K | ﹤0.01% | 8331 |
|
|
2021
Q1 | $3K | Buy |
+2
| New | +$4.29K | ﹤0.01% | 8517 |
|
Other funds holding INM
SM
VF
TSS
PWMG
SS
FDCDDQ